DALY II Japan/MB-CART2019.1 for DLBCL

Clinical trial NCT07288879 · RECRUITING

Trial details

NCT number: NCT07288879
Sponsor: Miltenyi Biomedicine GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

DLBCL - Diffuse Large B Cell Lymphoma CAR T Cell Therapy

Start date: 2025-12-11
Primary completion: 2027-01-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.